Document is current

Article History

Accepted: 9 August 2024

First Online: 22 August 2024

Declarations

:

: Open access funding provided by Alma Mater Studiorum - Università di Bologna within the CRUI-CARE Agreement.

: PGC, FP, and PV conceptualized the work. PGC, ST, EZ, and FP wrote the manuscript. PGC, ST, and EZ collected the clinical data and performed the analysis. FP and PV supervised the entire work. All authors have read and agreed to the published version of this manuscript.

: Pier Giorgio Cojutti received fees from Angelini, Shionogi, Pfizer, and MSD outside of the submitted work. Federico Pea reports personal fees from Angelini, Basilea Pharmaceutica, Gilead, Hikma, MSD, Pfizer, Sanofi-Aventis, Shionogi, Thermo Fisher, and Accelerate Diagnostics, outside the submitted work; has participated in speakers’ bureaus for Accelerate Diagnostics, Angelini, Basilea Pharmaceutica, Gilead, Hikma, MSD, Pfizer, Sanofi-Aventis, Shionogi, and Thermo Fisher; and has been a consultant for Angelini, Basilea Pharmaceutica, Gilead, MSD, Pfizer, and Shionogi, outside the submitted work. Pierluigi Viale has served as a consultant for bioMérieux, Gilead, Merck Sharp and Dohme, Nabriva, Nordic Pharma, Pfizer, Thermo-Fisher, and Venatorx, and has received payment for serving on the speakers’ bureaus for Correvio, Gilead, Merck Sharp, and Dohme, Nordic Pharma, and Pfizer, outside the submitted work. Sara Tedeschi and Eleonora Zamparini report no potential conflicts of interest that may be relevant to the contents of this study.

: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the IRCCS, Azienda Ospedaliero-Universitaria di Bologna (protocol code 897/2021/Oss/AOUBo).

: Patient consent was waived due to the retrospective and observational nature of the present investigation, according to hospital agreements.

: The data presented in this study are available upon request from the corresponding author. The data are not publicly available due to privacy concerns. The de-identified individual participant data that underlie the results reported in this article (including text, tables, and figures) will be made available, together with the research protocol for non-commercial, academic purposes. Additional supporting documents may be available on request.

: Not applicable.

: Not applicable.